Total Funding
86
82
Total FundingVenture - Series Unknown raised
Growth Score
0 pts
Heat Score
17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
6246
Halia Therapeutics is a biopharmaceutical company manufacturing therapies to improve the lives of patients with inflammatory disorders.
- Margit Amsbury: CSO
- Paul Jones: Chief Strategy Officer and GM, International MarketsPast Role: M42, Chief Executive Officer
About the Company
Halia Therapeutics is a preclinical-stage biopharmaceutical company manufacturing novel therapies to improve the lives of patients with inflammatory disorders and neurological diseases. Halia Therapeutics does this by advancing innovative medicines that target the immune system's response to resolve chronic inflammation and eliminate the
damage caused by aberrantly activated immune responses. Halia Therapeutics takes a novel approach to drug discovery by translating advances in understanding of the role of inflammation in human pathologies such as cancer and neurodegenerative diseases.
